Navigation Links
Neuro-Biotech Corp. Neuroceuticals® : A solution to feed the brain

Neuro-Biotech Corp. Neuroceuticals® : A solution to feed the brain

Advanced Search Search

  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Biotechnology, New Products & Services Click to view news release full screen  

Neuro-Biotech Corp. Neuroceuticals® : A solution to feed the brain


BASEL, Switzerland, Nov. 10 /PRNewswire/ - Neuro-Biotech Corporation (PINKSHEET: MRES) (OTCQB: MRES)

Neuro-Biotech Corp. is currently actively working towards the commercialization of natural products called "Neuroceuticals®", that are specially designed to restore the nervous system equilibrium and improve the state of health as well as the quality of life of people affected by stress-related disorders.

Our "Neuroceuticals®" respect international established quality standards (USP, EP and JP) in regards with purity, strength, and consistency of the products for human consumption.

According with our licences, we have a portfolio of four (4) innovative and selective products.

  • Neuro-Relax®
    A protein based supplement that favours the sleep's quality, decreases the anxiety and nervous pressure, improves general anxiety, anxious disorders, physical, emotional and mental stress and has a tranquilizing and soothing effect
  • Neuro-Learn®
    An adaptogene that helps stimulating the noradregenic and cholinergic systems resulting in improvement with memory, depression, concentration, attention and vigilance in particular with children suffering from attention deficit disorder which often need treatment with methylphenidate, among others marketed under the name of Ritalin®.
  • Neuro-Stim®
    An adoptogene which effect results in an increase in energy in order to reduce the effects of depression, hypoglycaemia, stress, obesity and type II diabetes as well as food behaviour's disorders such as bulimia.
  • Neuro-Lean®
    A product specially conceived to help with weight-loss management, optimizing the energetic spending as well as maintaining body weight.
  • Those four (4) products will be sold and distributed by many means; directly from us under our own label as well as through "Private labels" such as pharmacies, megastore and natural products brands. Since we are actively in a negotiation process, it will be the distributor's mandate, in terms of their respective part of the market, to target the clientele they believe should be reached.

    For more detailed information on the scientific data and the Neuroceuticals®, we invite you to consult our website at under the products section.

    Neuro-Biotech is currently negotiating with 2 separates groups on the East coast and West coast for them to distribute the Neuroceuticals®. Management also decided that in order to maximize the market penetration and based on the product composition, it was it the Company's best interest to categorize the Neuroceuticals® as Natural Products and Food Supplements.

    For more information, do not hesitate to contact us by using the contact form on our corporate website at Your request will be transferred to the appropriate persons and we will get back to you as soon as possible.

    SOURCE Neuro-Biotech Corp.
    Copyright©2010 PR Newswire.
    All rights reserved

    Related biology technology :

    1. Mr Claude Poulin nominated as President and CEO of Neuro-Biotech Corp.
    2. Neuro-Biotechs Solution for a Doctor near You: Early Detection for Alzheimers and Chronic Fatigue Syndrome!
    4. NEURO-BIOTECH CORPORATION: Updates and latest developments
    5. BioSpecifics Technologies Corp. Reports Second Quarter 2008 Financial Results
    6. InstaCare Corp. Continues Turnaround & Reports 291% Revenues Increase in 2Q 2008
    7. ThermoGenesis Corp. to Announce Fourth Quarter and Year End Results for Fiscal 2008 on September 9, 2008
    8. BioSpecifics Technologies Corp. Buys Down Royalties for Peyronies Disease
    9. Aegis Analytical Corp. Showcases Discoverant at Inaugural Venture Capital in the Rockies Fall
    10. BioElectronics Corp. Announces $400,000 in New Orders From the Middle East
    11. BioSpecifics Technologies Corp. Announces Appointment of Dr. Matthew Geller to Board of Directors
    Post Your Comments:
    (Date:11/24/2015)... Telbec/ - ProMetic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) ... Laurin , President and Chief Executive Officer of ProMetic, will ... 27 th Annual Healthcare Conference to be held at ... st , at 8.50am (ET) and ProMetic,s management ... The presentation will be available live via a webcast accessible ...
    (Date:11/24/2015)... Va. , Nov. 24, 2015 ... focused on discovering drugs for metabolic disorders, announced ... to its Board of Directors (BOD). Mr. ... officer of Human Genome Sciences (HGS), and also ... Organization. Jim Powers , Chairman and ...
    (Date:11/24/2015)... and NEW YORK , November 24, ... investment by Bristol-Myers Squibb in a European ... Bristol-Myers Squibb Company in which the companies will work ... immuno-oncology and other areas of unmet medical need. The collaboration ... LSP 5, the latest LSP fund. This is the first ...
    (Date:11/24/2015)... -- According to two new studies, fewer men are having ... many doctors, scientists, and public health experts have been pushing ... tests being done, will there be more men dying of ... "Despite the efforts made in regards to early detection ... cause of death in men, killing approximately 27,500 men this ...
    Breaking Biology Technology:
    (Date:11/17/2015)... , Nov. 17, 2015  Vigilant Solutions announces today ... its Board of Directors. --> ... recently retiring from the partnership at TPG Capital, one ... with over $140 Billion in revenue.  He founded and ... all the TPG companies, from 1997 to 2013.  In ...
    (Date:11/12/2015)... , Nov. 11, 2015   Growing need ... analytical tools has been paving the way for ... determination of discrete analytes in clinical, agricultural, environmental, ... being predominantly used in medical applications, however, their ... sectors due to continuous emphasis on improving product ...
    (Date:11/9/2015)... 2015  Synaptics Inc. (NASDAQ: SYNA ), the ... entry into the automotive market with a comprehensive and ... of consumer electronics human interface innovation. Synaptics, industry-leading touch ... the automotive industry and will be implemented in numerous ... , Japan , and ...
    Breaking Biology News(10 mins):